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Abstract
Background: Profilins are critical to cytoskeletal dynamics in eukaryotes; however, little is known
about their viral counterparts. In this study, a poxviral profilin homolog, ectromelia virus strain
Moscow gene 141 (ECTV-PH), was investigated by a variety of experimental and bioinformatics
techniques to characterize its interactions with cellular and viral proteins.
Results: Profilin-like proteins are encoded by all orthopoxviruses sequenced to date, and share
over 90% amino acid (aa) identity. Sequence comparisons show highest similarity to mammalian
type 1 profilins; however, a conserved 3 aa deletion in mammalian type 3 and poxviral profilins
suggests that these homologs may be more closely related. Structural analysis shows that ECTV-
PH can be successfully modelled onto both the profilin 1 crystal structure and profilin 3 homology
model, though few of the surface residues thought to be required for binding actin, poly(L-proline),
and PIP2 are conserved. Immunoprecipitation and mass spectrometry identified two proteins that
interact with ECTV-PH within infected cells: alpha-tropomyosin, a 38 kDa cellular actin-binding
protein, and the 84 kDa product of vaccinia virus strain Western Reserve (VACV-WR) 148, which
is the truncated VACV counterpart of the orthopoxvirus A-type inclusion (ATI) protein. Western
and far-western blots demonstrated that the interaction with alpha-tropomyosin is direct, and
immunofluorescence experiments suggest that ECTV-PH and alpha-tropomyosin may colocalize to
structures that resemble actin tails and cellular protrusions. Sequence comparisons of the poxviral
ATI proteins show that although full-length orthologs are only present in cowpox and ectromelia
viruses, an ~ 700 aa truncated ATI protein is conserved in over 90% of sequenced orthopoxviruses.
Immunofluorescence studies indicate that ECTV-PH localizes to cytoplasmic inclusion bodies
formed by both truncated and full-length versions of the viral ATI protein. Furthermore,
colocalization of ECTV-PH and truncated ATI protein to protrusions from the cell surface was
observed.
Conclusion: These results suggest a role for ECTV-PH in intracellular transport of viral proteins
or intercellular spread of the virus. Broader implications include better understanding of the virus-
host relationship and mechanisms by which cells organize and control the actin cytoskeleton.
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Profilins are critical to the cytoskeletal dynamics required
for determination of cell shape and size, adhesion, cytoki-
nesis, contractile force, morphogenesis and intracellular
transport. Members of the profilin family of proteins are
known to be key regulators of actin polymerization in
eukaryotic organisms ranging from yeast to mammals, but
little is known about profilin homologs found in the pox-
viridae and paramyxoviridae virus families [1,2].
Poxviruses are complex viruses with large double-
stranded DNA genomes that encode many proteins not
required for virus replication in tissue culture [3]. Some
non-essential genes are involved in blocking host
immune functions, while others function in pathogene-
sis-related pathways [4,5]. Most poxvirus genes, in fact,
are not universally conserved and, as might be expected,
some are found only in phylogenetically related sub-
groups of the poxvirus family. The poxvirus gene that
encodes a homolog of cellular profilin is such a gene and
appears to have been acquired by an ancestral orthopox-
virus since it is present in all fully sequenced orthopoxvi-
rus genomes (79 to date; [6,7]), but absent from all other
poxviruses. All of the poxvirus profilin homologs share
90% or greater protein sequence identity (data not
shown).
Cellular profilins are believed to interact with three types
of cellular molecules: actin monomers, phosphatidyli-
nositol 4,5-bisphosphate (PIP2) and poly(L-proline)
sequences [8]. Profilins are thought to modulate actin fil-
ament dynamics (polymerization and depolymerization)
via direct binding to actin through an actin-binding
domain as well as by modulation of other actin-binding
proteins [9]. Over 50 proteins have been characterized as
profilin ligands [8]. Numerous proteins interact with pro-
filin directly through the poly(L-proline) binding
domain, while others may bind indirectly to profilin-reg-
ulated complexes or have their activities altered by these
complexes [8]. Profilins also assist in signalling between
cell membrane receptors and the intracellular microfila-
ment system by their interaction with phosphoinositides
[10]. Though many of the interactions with phosphoi-
nositides and profilin-binding proteins remain poorly
understood, profilin has been implicated in diverse proc-
esses involving actin, nuclear export receptors, endocyto-
sis regulators, Rac and Rho effectors, and putative
transcription factors [8].
In contrast to its cellular homolog, the vaccinia virus pro-
filin-homolog (VACV-PH) binds actin only weakly, has
no detectable affinity for poly(L-proline), and, although it
has a similar affinity for PIP2 [11], does not show signifi-
cant binding to phosphatidyl inositol (PI) or inositol tri-
phosphate (IP3) [12]. Little, therefore, is known about
poxviral profilin function. However, RNA interference
knockdown studies of the respiratory syncytial virus (RSV)
profilin homolog showed that absence of this viral profi-
lin had a small effect on reducing viral macromolecule
synthesis and strongly inhibited maturation of progeny
virions, cell fusion, and induction of stress fibers [1]. The
RSV profilin homolog has been found to interact with RSV
phosphoprotein P and nucleocapsid protein N. These
interactions are thought to help activate viral RNA-
dependent RNA polymerase [1].
Although the importance of actin filaments in poxvirus
motion (and therefore cell-to-cell spread) is well under-
stood, the specific interactions involved are not yet well-
characterized [13-16]. Although viral profilin binds actin
only weakly, its significant sequence similarity to cellular
profilin suggested that it was a possible component in this
pathway. Using the murine smallpox model, ectromelia
virus, we initiated a search for proteins that interact with
the ectromelia profilin homolog, ECTV-PH.
Herein we present evidence that ECTV-PH interacts with
cellular α-tropomyosin and both full-length and trun-
cated viral ATI proteins in infected cells and colocalizes to
inclusion bodies and protrusions from the cells at puta-
tive actin-like tails. Many of the residues important for
binding actin and other known mammalian substrates are
not conserved in ECTV-PH; however, the ECTV-PH pro-
tein can be modelled onto the related structures of mam-
malian profilins 1 and 3.
Results and discussion
Sequence analysis of profilin
We began our study of ECTV-PH by comparing it to vari-
ous cellular profilin proteins using multiple sequence
alignments. The mouse type 1 profilins appear to be most
similar (~ 31% aa identity) to their orthopoxviral counter-
part; mouse type 2 and type 3 profilins are ~ 25% and ~
23% identical to the viral protein respectively (Figure 1A).
An alignment of ECTV-PH and type 1, 2 and 3 profilins
from mouse, human, cow, and rat showed that sequence
identity conservation between each of these mammalian
sequences compared to ectromelia sequence was similar
to the reported percent identities for mouse profilins and
ECTV-PH (within 1.5%; data not shown). Though analy-
sis using a maximum likelihood tree (Figure 1B) supports
these findings, another phylogenetic tool, maximum par-
simony, places the poxviral homolog slightly closer to the
type 3 profilins [2]. Although the first two methods are
considered to be more reliable than maximum parsimony
analysis, another piece of evidence – a shared 3-aa dele-
tion in the viral and type 3 profilin genes – supports the
maximum parsimony result. These data, apparently con-
tradictory, could be explained by an ancestral orthopoxvi-
rus acquiring a type 3 profilin gene from its host, andPage 2 of 15
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higher similarity with type 1 profilin.
Structural Analysis of the ECTV-PH
To provide further insight into viral profilin function,
three-dimensional structural modelling of ECTV-PH was
carried out. As discussed above, the sequence data indi-
cates that ECTV-PH is closer to human profilin 1 (31%
sequence identity) than 3 (23%). However, previous work
has classified ECTV-PH with profilin 3 [2]. SWISS-
MODEL [17] was used to model the structures of both
ECTV-PH and human profilin 3 (NP_001025057.1), and
each of these structures was subsequently compared by
superposition to the crystal structure of human profilin 1
(PDB ID: 1FIL) [18]. We chose to show all comparisons to
human profilin 1 since it is the only one of the three pro-
teins that has a crystal structure in the PDB database (Fig-
ures 2, 3, 4). According to the root mean square deviation
(RMSD) values (Table 1), ECTV-PH is closest to human
profilin 3 with an RMSD value of 0.500 over 132 atoms;
however, the RMSD value for human profilin 1 is 0.551
over 132 atoms and, therefore, cannot be ruled out as the
closest homolog of ECTV-PH. The structure of ECTV-PH
was also compared to the crystal structure of the human
profilin 2b protein (1D1J chain D; [19]) as well as a hom-
ology model of human profilin 2a; however, these struc-
tures showed significantly lower structural similarity to
ECTV-PH (RMSD 0.95 over 130 atoms; data not shown).
(A) T-Coffee alignment of viral and murine profilin sequences visualized with the Base-By-Base interfaceFigure 1
(A) T-Coffee alignment of viral and murine profilin sequences visualized with the Base-By-Base interface. Minor manual adjust-
ments were made to the alignment based on structural analysis. Shading of individual residues indicates the degree of residue 
conservation between sequences (darkest = identical aa in all sequences; no shading = zero conservation). A consensus 
sequence is shown below the alignment. (B) Phylogenetic tree using maximum likelihood analysis for the mammalian profilin 
sequences available in GenBank, and ECTV-PH. The percentage bootstrap support (100 samples) is indicated along the 
branches.
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62% identical to type 1 profilins and ~ 40% identical to
type 3 profilins, yet the structural similarity is relatively
low (RMSD ~ 0.99 and ~ 0.98, respectively). When profi-
lin 1 and 3 are compared they have a similar % identity (~
43%) but much greater structural similarity (RMSD ~
0.41). The structure of ECTV-PH was also modelled using
the Robetta protein structure prediction server [20-22]
and was found to be nearly identical in structure to the
model created by SWISS-MODEL. Slight differences in the
Structural comparison of the poly(L-proline) binding site of ECTV-PH and human profilin 1Figure 3
Structural comparison of the poly(L-proline) binding site of 
ECTV-PH and human profilin 1. (A) Surface diagrams of the 
ECTV-PH structural model and the human profilin 1 crystal 
structure using a blue background with the important poly(L-
proline) binding residues coloured in green. The dark red 
residue represents the one residue (W-5 in ECTV-PH, W-3 
in human profilin 1) that is identical between both structures; 
the orange residue represents the one functionally con-
served residue (V-129 in ECTV-PH, L-134 in human profilin 
1). (B) Surface diagrams of ECTV-PH and human profilin 1 
with residues coloured by amino acid property as follows: 
aromatic residues (F, Y, W) in purple; negatively charged res-
idues (D, E) in red; positively charged residues (R, H, K) in 
dark blue; non-polar/aliphatic residues (G, I, L, M, V) in gold; 
and polar/uncharged residues (N, Q, P, S, T) in light blue.
Table 1: Root mean square deviation (RMSD) values for the superposition of human profilin 1 with ECTV-PH and human profilin 3. 
The right-most column gives the number of atoms over which the superposition was made
Structure 1 Structure 2 RMSD Number of atoms
Human profilin 1 ECTV-PH 0.551 132
Human profilin 3 ECTV-PH 0.5 132
Human profilin 1 Human profilin 3 0.411 136
Structural comparison of the actin binding site of ECTV-PH and hum n profilin 1Figure 2
Structural comparison of the actin binding site of ECTV-PH 
and human profilin 1. (A) Surface diagrams of the ECTV-PH 
structural model and the human profilin 1 crystal structure 
using a blue background with the important actin binding res-
idues coloured in green. The dark red residue represents the 
one residue (V-70 in ECTV-PH, V-72 in human profilin 1) 
that is identical between both structures; the orange residues 
represent two functionally conserved residues (R-120 in 
ECTV-PH, K-125 in human profilin 1 and D-124 in ECTV-PH, 
E129 in human profilin 1). (B) Surface diagrams of ECTV-PH 
and human profilin 1 with residues coloured by amino acid 
property as follows: aromatic residues (F, Y, W) in purple; 
negatively charged residues (D, E) in red; positively charged 
residues (R, H, K) in dark blue; non-polar/aliphatic residues 
(G, I, L, M, V) in gold; and polar/uncharged residues (N, Q, P, 
S, T) in light blue.Page 4 of 15
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the only differences observed between the Robetta and
SWISS-MODEL models of ECTV-PH (data not shown).
Human profilin contains 3 major binding domains for
actin, poly(L-proline), and phosphatidylinositol 4,5-
bisphosphate (PIP2). While the overall tertiary structure
of ECTV-PH is highly conserved compared to both human
profilins 1 and 3, with the closest relationship to human
profilin 3, the amino acids comprising the binding
regions on ECTV-PH are almost entirely different. ECTV-
PH has been previously observed to have a low affinity for
both actin and poly(L-proline) compared to human pro-
filin 1 [11]. Our structural analysis supports this observa-
tion as most amino acids critical for binding in human
profilin are not conserved in ECTV-PH in terms of identity
or function; 20 of the 21 residues important for actin
binding and 5 of the 6 important for poly(L-proline)
binding in both human profilin 1 and 3 are not conserved
in ECTV-PH (Table 2). Figures 2 and 3 illustrate this lack
of conservation; known human profilin 1 binding resi-
dues for actin and poly(L-proline) are shown in green,
while the one identical residue shared with ECTV-PH in
each case appears in red. Orange represents functionally
conserved residues, two for actin binding and one for
poly(L-proline) binding.
Comparisons with human profilin regarding PIP2 binding
are more difficult. A range of binding affinities has been
reported for human profilin 1 (0.13 μM < Kd < 35 μM)
depending on the experimental method used [2,10,23].
Most recently, a dissociation constant of 985 μM was
obtained using a relatively more biologically relevant
assay that employed sub-micellar concentrations of PIP2
[10]. Because of this uncertainty in the literature, it is dif-
ficult to quantitatively compare the affinities of ECTV-PH
and human profilin 1 for PIP2. Of the 6 amino acids
important for PIP2 binding in human profilin 1 and 3, 5
residues are not conserved in ECTV-PH (Figure 4, Table 2)
suggesting that it should have little or no binding affinity
to PIP2. Given that Machesky observed a significant bind-
ing affinity of ECTV-PH for PIP2, (Kd = 1.3 μM) [11], it is
probable that nearby residues contribute to PIP2 binding.
The loop located between beta-strands 5 and 6 of human
profilin 1 has been weakly implicated in PIP2 binding
[24], and is substantially smaller in ECTV-PH (Figure 4).
It has previously been suggested that a smaller, less obtru-
sive loop could contribute to a lower binding affinity to
PIP2 [24], and the observed data would seem to fit this
hypothesis.
Thus, despite low sequence similarity and lack of con-
served binding residues for actin, poly(L-proline), and
PIP2, a relatively high level of structural similarity between
viral and mammalian profilin is maintained. Further stud-
ies may show this structural conservation reflects func-
tional conservation or, alternatively, adaptation of a
stable protein structure by the virus for new functionality.
ECTV-PH-interacting proteins
The first experimental step utilized immunoprecipitations
to identify proteins interacting with ECTV-PH in tissue
culture cells. BS-C-1 cells were infected with a recom-
binant VACV strain WR vTF7-3 expressing a T7 polymer-
ase, and then transfected with a plasmid containing the
gene of interest, a Histidine (His)-tagged ECTV-PH. Late
in infection (after 16 h), proteins were extracted from the
cell and subjected to a penta-His antibody to selectively
precipitate ECTV-PH and any associated proteins. Inter-
acting proteins were affinity captured on Protein-G agar-
ose and subjected to SDS-PAGE analysis. The resulting gel
Structural comparison of the PIP2 binding site of ECTV-PH and hum n profilin 1Figure 4
Structural comparison of the PIP2 binding site of ECTV-PH 
and human profilin 1. (A) Surface diagrams of the ECTV-PH 
structural model and the human profilin 1 crystal structure 
using a blue background with the important PIP2 binding resi-
dues coloured in green. The dark red residue represents the 
one residue (R-130 in ECTV-PH, R-135 in human profilin 1) 
that is identical between both structures; the orange residue 
represents the one functionally conserved residue (R-120 in 
ECTV-PH, K-125 in human profilin 1.) (B) Surface diagrams 
of ECTV-PH and human profilin 1 with residues coloured by 
amino acid property as follows: aromatic residues (F, Y, W) 
in purple; negatively charged residues (D, E) in red; positively 
charged residues (R, H, K) in dark blue; non-polar/aliphatic 
residues (G, I, L, M, V) in gold; and polar/uncharged residues 
(N, Q, P, S, T) in light blue. The arrows in panels A and B 
indicate the loop located between beta-strands 5 and 6 of 
human profilin 1 implicated in PIP2 binding that is reduced in 
size in ECTV-PH.Page 5 of 15
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using cell lysate containing no ECTV-PH (bands are pro-
teins that interact non-specifically with precipitating
agents.) Four bands appear in lane 2 that are not present
in lane 1; of these, the 16 kDa and 28 kDa bands are
unbound ECTV-PH monomers and dimers, respectively.
We have shown by western blotting that this protein can
maintain a dimerized form, despite the denaturing condi-
tions of an SDS-PAGE gel (data not shown). The 38 and
84 kDa bands are proteins that interact with ECTV-PH.
These were excised from the gel and identified via mass
spectrometry as VACV-WR 148, an 84 kDa protein which
belongs to the orthopoxvirus A-type inclusion (ATI) pro-
tein family (protein accession no. AA089427.1), and α-
tropomyosin, a 38 kDa cellular actin-binding protein
(protein accession no. AAA61226). Although lane 2 is
slightly under-loaded relative to lane 1, the non-specific
interacting proteins are generally comparable between the
two lanes. It is interesting, however, that some of the pro-
teins appear to migrate slightly faster in lane 2; this may
represent differential protein processing in virus infected
cells.
As tropomyosin is an actin-binding protein and viral pro-
filin is known to bind actin (though weakly in the case of
viral profilin [11]), two additional investigations were
performed that demonstrate the tropomyosin-profilin
interaction is direct. Firstly, a western blot of the immuno-
precipitated ECTV-PH sample with a polyclonal anti-actin
primary antibody failed to detect actin (Figure 6). Lanes 1
and 2 contain purified rabbit muscle actin and starting
cell lysate from which ECTV-PH and ECTV-PH-interacting
proteins were isolated, respectively. Strong immunoreac-
tive bands at 42 kDa are observed in both lanes, indicating
significant levels of actin in the initial cell lysate. Lane 3
contains proteins that coimmunoprecipitated with ECTV-
PH; no immunoreactive band at 42 kDa indicates that if
actin is present, levels are below the detection threshold of
the western blot. These data agree with findings (dis-
cussed earlier) that the viral profilin homolog has a low
binding affinity for actin [9]. The immunoreactive band at
17 kDa corresponds to the MW of Protein G (precipitating
agent), indicating that it retains some capacity to bind to
antibodies even after separation by SDS-PAGE and trans-
fer to blotting membrane.
Table 2: Comparison of residues important in actin, poly(L-proline) and PIP2 binding in human profilin 1, human profilin 3 and ECTV-
PH. Identical and functionally conserved residues are indicated with an asterisk
Residue in human profilin 1 Equivalent residue in human 
profilin 3
Equivalent residue in ECTV-PH Function in human profilin 1
W3 W4 W5 Poly(L-proline) binding*
Y6 Y7 I8 Poly(L-proline) binding
W31 W32 L33 Poly(L-proline) binding
Y59 L60 - Actin binding
V60 Q61 - Actin binding
N61 A62 - Actin binding
K69 R70 F67 Actin and PIP2 binding
S71 C72 I69 Actin binding
V72 V73 V70 Actin binding*
I73 I74 Y71 Actin binding
R74 R75 T72 Actin binding
E82 D83 T80 Actin binding
R88 R89 L86 Actin and PIP2 binding
K90 K91 G88 Actin and PIP2 binding
T97 A95 V92 Actin binding
N99 A97 P94 Actin binding
V118 V116 T113 Actin binding
H119 H117 S114 Actin binding
G121 G119 R116 Actin binding
L122 I120 E117 Actin binding
N124 N122 Y119 Actin binding
K125 K123 R120 Actin and PIP2 binding*
Y128 H126 R123 Actin binding
E129 E127 D124 Actin binding*
H133 G131 N128 Poly(L-proline) binding
L134 L132 V129 Poly(L-proline) binding*
R135 R133 R130 PIP2 binding*
R136 M134 A131 PIP2 binding
Y139 A137 N134 Poly(L-proline) bindingPage 6 of 15
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this His-tag on the ECTV-PH protein. A far-western blot
was performed, using nickel-column purified ECTV-PH
probed with porcine muscle tropomyosin protein and
detected with mouse monoclonal anti-tropomyosin IgG1
primary antibody (Figure 7, lane 2). Since no tropomy-
osin bound to a His-tagged control protein or BSA, we
concluded that the interaction is not due to the His-tag
(Figure 7, lanes 4 and 5).
Sequence analysis of viral A-type inclusion proteins
The next step was to investigate the poxviral ATI proteins
that interact with ECTV-PH. The majority of orthopoxvi-
ruses encode an ATI protein that is expressed late in infec-
tion at approximately the same time as the profilin
homolog [25]. ATI proteins are present either as a full-
length protein, found in cowpox virus (CPXV) and ECTV,
or a truncated form of the protein found in most other
orthopoxviruses. Full-length ATI proteins form large bod-
ies in the cytoplasm that contain intracellular mature vir-
ions (IMV), and are thought to be important in survival
and dissemination of the virions [26,27]. Although the
function of truncated ATI proteins is poorly understood,
in VACV they do associate with mature virions [26], and
the conservation of these truncated genes suggests the pro-
tein does confer an advantage to the virus during its life
cycle.
Western blot to test for actin in coimmunoprecipitates using rabbit IgG anti-actin primary antib dyFigure 6
Western blot to test for actin in coimmunoprecipitates using 
rabbit IgG anti-actin primary antibody. Lane 1, purified rabbit 
muscle actin showing an immunoreactive band at 42 kDa 
(positive control). Lane 2, starting cell lysate showing pres-
ence of actin. Lane 3, proteins that coimmunoprecipitated 
with ECTV-PH as described in Figure 2 showing absence of 
detectable actin.
Coimmunoprecipitation of proteins that interact with ECTV-PHFigure 5
Coimmunoprecipitation of proteins that interact with ECTV-
PH. His-tagged ECTV-PH was immunoprecipitated with 
mouse monoclonal anti-His antibodies and Protein G-Plus 
agarose along with any bound proteins from a BS-C-1 cell 
lysate. Proteins were separated by SDS-PAGE and stained 
with Coomassie blue. Lane 1, control immunoprecipitation; 
lysate contained no His-tagged ECTV-PH. Lane 2, proteins 
isolated from immunoprecipitation on cells expressing His-
tagged ECTV-PH. Three bands at 16 kDa, 38 kDa and 84 kDa 
were excised from the gel and identified by mass spectrome-
try as indicated; a fourth band at 28 kDa was identified as a 
dimer of ECTV-PH in a western blot.
VACV-ATI
Tropomyosin 
ECTV-PHPage 7 of 15
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genomes sequenced to date (66 out of 73 total). Interest-
ingly, the CPXV and ECTV ATI proteins are approximately
60% longer than the highly conserved truncated version.
The longest ATI protein, 1284 aa in length, is encoded by
CPXV strain Brighton Red. The first ~ 600 residues, con-
served in the truncated version, are followed by a series of
10 tandem peptide repeats, each 24–32 aa long, and a car-
boxyl (C)-terminal region of ~ 380 residues (Figure 8).
Several of these repeats are absent in ECTV-ATI; other
orthopoxviruses have larger deletions in the repeat region
as well as in the C-terminus. The ATI gene is completely
absent from several monkeypox and VACV genomes, and
is, therefore, not essential to virus replication. However,
the widespread conservation of the truncated portion
indicates that this gene likely encodes a beneficial and
selectable trait.
Localization of the ECTV-PH and VACV-WR A-type 
inclusion proteins in infected cells
To determine if ECTV-PH and VACV-WR 148 (a truncated
ATI protein) colocalize in poxvirus-infected cells, hemag-
glutinin (HA)-tagged VACV-WR 148 (VACV-ATI) and
Myc-tagged ECTV-PH were co-expressed with the vTF7-3
transient expression system and visualized by indirect
immunofluorescence. Since anti-His antibodies are
known to cross-react with cellular proteins, a Myc-tagged
ECTV-PH expression plasmid was constructed for use with
the vTF7-3 virus in place of the His-ECTV-PH. A mock-
infected control cell stained with both anti-HA and anti-
Myc antibodies as well as 4'6-diamidino-2-phenylindole
(DAPI) DNA staining is shown in Figure 9A; very little
background antibody binding is seen. Figure 9B shows an
infected cell subjected to DAPI staining (blue fluorescence
indicates the nucleus). In the infected cell, both VACV-ATI
(Figure 9C; green fluorescence) and ECTV-PH (Figure 9D;
red fluorescence) are visible throughout the cytoplasm.
However, several regions have brighter immunofluores-
cence signals for both proteins; the merge view suggests
that these are sites of colocalization (Figure 9E arrows 1–
3). Truncated ATI proteins have been observed to aggre-
gate and form small, irregularly-shaped, unstable inclu-
sion bodies [28]. The morphology of the putative regions
of colocalization in Figure 9E (arrows 1 and 2) matches
this description. Two extranuclear regions stained for
DNA (Figure 9B arrows 1 and 2) overlap with the
observed bodies. If these are indeed unstable inclusion
bodies formed by aggregated truncated ATI proteins, this
evidence suggests that they are still able to sequester intra-
cellular mature virions (IMV). In contrast, the viral factory
indicated by arrow 4, a discrete area in the cytoplasm con-
taining actively replicating viral DNA, does not colocalize
to the putative inclusion bodies. Finally, ECTV-PH and
VACV-ATI also appear to colocalize to a structure near the
cell periphery (Figure 9E arrow 3), resembling protrusions
from the cell surface induced by cell-associated virions
(CEV) during infection.
Localization of the ECTV-PH and ECTV-Moscow A-type 
inclusion proteins in infected cells
To characterize the interaction between ECTV-PH and
full-length poxvirus ATI proteins, Myc-tagged ECTV-PH
and HA-tagged ECTV-Moscow-128 A-type inclusion
(ECTV-ATI) proteins were overexpressed and localized in
Far western blot probed with tropomyosin and detected with mouse anti-tropomyosin primary antibodiesigur  7
Far western blot probed with tropomyosin and detected 
with mouse anti-tropomyosin primary antibodies. (A) Lane 1, 
purified porcine muscle tropomyosin showing an immunore-
active band at 37 kDa (positive control). Lane 2, purified 
ECTV-PH; the immunoreactive band at 15 kDa represents its 
interaction with tropomyosin. Lane 3, purified rabbit muscle 
actin; immunoreactive bands at 42 kDa and 43 kDa represent 
tropomyosin interaction with different actin isoforms. Lanes 
4 and 5 contain His-tagged RelA and His-tagged bovine 
serum albumin respectively (negative controls); no immuno-
reactive bands are present. (B) Corresponding SDS-PAGE 
stained with Coomassie blue. Lane assignments are as 
described in (A).
B A 
Schematic of Poxviral ATI proteins shown in groups with similar sequencesFigure 8
Schematic of Poxviral ATI proteins shown in groups with 
similar sequences. Virus groups are abbreviated as follows: 
Cowpox virus (CPXV), Ectromelia virus (ECTV), Vaccinia 
virus (VACV), Horsepox virus (HSPV), Camelpox virus 
(CMLV), Taterapox virus (TATV), Variola virus (VARV), and 
Monkeypox virus (MPXV). Numbers indicate aa positions. 
Ten tandem repeats, as described by Osterrieder et al. [29], 
are represented by boxes labelled R1 through R10. Deletions 
are indicated by broken triangular lines. Double-backslashes 
indicate sequence not shown in the N- and C- terminal 
regions.Page 8 of 15
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tem and antibodies as previously described. ECTV-ATI has
been previously shown to form large, round inclusion
bodies in the cytoplasm of the host cell [29]. These bodies
are clearly visible in Figure 10C. Unlike VACV-ATI, the
ECTV-ATI protein appears to be completely localized to
these inclusions in the cytoplasm, which are excluded
from the nucleus as seen by DAPI staining (Figure 10B).
This complete localization to the inclusion bodies sup-
ports earlier findings that ATI proteins are associated only
with IMVs [19]. Though ECTV-PH also largely colocalizes
to these inclusion bodies (Figure 10D), some of the pro-
tein remains distributed throughout the cytoplasm. This
suggests that ECTV-PH may also interact with other pro-
teins in the cytoplasm, such as cellular tropomyosin (as
previously demonstrated in Figures 5 and 7). Viral DNA
(Figure 10B arrows 1 and 2) does not appear to localize to
the inclusion bodies.
Taken together, the results of these two immunofluores-
cence experiments suggest that ECTV-PH localizes to
inclusion bodies formed by both truncated and full-
length versions of the viral ATI protein in the cytoplasm of
the host cell. As the amino (N) terminus and first two tan-
dem repeats are the only domains these proteins share, it
is reasonable to conclude that this shared region contains
the site of interaction with the profilin homolog. In addi-
tion, the colocalization of viral profilin and truncated ATI
protein to protrusions from the cell surface suggests that
these proteins may together be involved in intercellular
transport of the virus.
Localization of the ECTV-PH and cellular tropomyosin 
proteins in infected cells
The role of tropomyosin is well understood in skeletal
muscle, where it regulates the actin-myosin interaction,
controlling muscle contraction. However, the role of tro-
pomyosin in the cytoskeleton has remained elusive. Actin
filaments vary in composition due to utilization of dis-
tinct isoforms of both actin and tropomyosin, which are
temporally and spatially regulated [30]. It has been dem-
onstrated that tropomyosin isoforms differentially regu-
late actin filament function and stability [30]. As ECTV-
PH binds tropomyosin and may be involved in actin
Investigation of colocalization of ECTV-PH and ECTV-ATI by immunofluorescenceFigure 10
Investigation of colocalization of ECTV-PH and ECTV-ATI by 
immunofluorescence. HA-tagged ECTV-ATI protein, a full-
length type ATI protein, and Myc-tagged ECTV-PH were 
overexpressed in virus-infected BS-C-1 cells using a vTF7-3 
transient expression system. (A) Control cells, infected with 
vTF7-3 and transfected with calf thymus DNA, show DAPI 
staining of cellular nuclei and little background staining with 
anti-HA and anti-Myc antibodies (negative control). (B) DAPI 
staining of cellular nuclei and viral DNA. Discrete areas of 
DNA in the cytoplasm are indicated by arrows 1 and 2. (C) 
ECTV-ATI (green) is present only in discrete areas (large 
inclusion bodies) located in the cytoplasm. (D) ECTV-PH 
(red) partially localizes to inclusion bodies as well as being 
partially distributed throughout the cytoplasm. (E) Merged 
view of panels (B-D) shows localization of ECTV-PH and 
ECTV-ATI, but not viral DNA, to inclusion bodies.
HA (ECTV-ATI)
Myc (ECTV-PH)
Investigation of colocalization of ECTV-PH and VACV-ATI by immunofluorescenceFigure 9
Investigation of colocalization of ECTV-PH and VACV-ATI by 
immunofluorescence. HA-tagged VACV-ATI protein, a trun-
cated-type ATI protein, and Myc-tagged ECTV-PH were 
overexpressed in BS-C-1 cells using a vTF7-3 transient 
expression system. (A) Control cells, infected with vTF7-3 
and transfected with calf thymus DNA, show DAPI staining 
of cellular nuclei and little background staining with anti-HA 
and anti-Myc antibodies (negative control). (B) DAPI staining 
of cellular nuclei and viral DNA. Discrete areas of DNA in 
the cytoplasm are indicated by arrows 1, 2 and 4. (C) VACV-
ATI protein (green) and (D) ECTV-PH (red) are both distrib-
uted throughout the cytoplasm. Arrows 1, 2 and 3 indicate 
areas of high protein colocalization. (E) Merged view of pan-
els (B-D). Arrows 1 and 2 indicate putative inclusion bodies 
where VACV-ATI, ECTV-PH, and viral DNA colocalize. 
Arrow 3 indicates the colocalization of VACV-ATI and 
ECTV-PH to a putative protrusion from the cell surface.
E
Myc (ECTV-PH) 
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PH and cellular tropomyosin in poxvirus-infected cells
using indirect immunofluorescence.
Endogenous cellular tropomyosin was relatively uni-
formly distributed throughout the cytoplasm in the mock-
infected control cells (Figure 11A; green fluorescence). In
the infected cell, both tropomyosin (11C, green fluores-
cence) and ECTV-PH (11D, red fluorescence) were also
observed throughout the cytoplasm. Neither is present in
the nucleus, as is shown by DAPI DNA staining (11B; blue
fluorescence). It is possible that tropomyosin and ECTV-
PH interact with each other in the cytoplasm and/or with
different cytoplasmic proteins, though due to the wide-
spread distribution of both, no definite conclusions are
possible.
Intriguingly, some ECTV-PH and the endogenous cellular
tropomyosin appear to colocalize in higher concentra-
tions to structures resembling actin tails (Figure 11E,
arrows labelled 1); these are known to support extracellu-
lar enveloped virus (EEV)-containing protrusions from
the cell surface (Figure 11E, arrows labelled 2) that are
important for the intercellular spread of poxviruses [31].
ECTV-PH (but not tropomyosin) also localizes in high
concentrations to structures resembling inclusion bodies
(arrows labelled 3). These are presumably aggregates of
the truncated ATI protein encoded by vTF7-3, the recom-
binant vaccinia virus used in the transient expression sys-
tem. Though similar to the inclusion bodies formed when
the truncated VACV-ATI is overexpressed (Figure 9E
arrows 1 and 2), those seen here are more spherical, sug-
gesting that overexpression of the protein may affect the
morphology of the putative inclusion bodies.
Summary of the Immunofluorescence Results
Our immunofluorescence results show that full-length
ECTV-ATI and ECTV-PH colocalize to inclusion bodies,
where IMVs are known to be sequestered [27]. Truncated
ATI proteins do not form stable inclusion bodies, and the
structures formed are seen to be small and irregularly
shaped in our study in agreement with previous work
[28], yet we observed some colocalization of ECTV-PH
and VACV-ATI proteins to putative inclusion bodies and
protrusions on the cell surface. IMV particles have been
shown to travel along microtubules and form intracellular
enveloped virus (IEV) particles that then travel to the cell
surface [15]. Our results suggest that profilin may be
involved with inclusion bodies and IMV transport.
Though the immunofluorescence data for tropomyosin
are less conclusive, it is possible that tropomyosin and
ECTV-PH are also involved in release and/or intercellular
transport of viral particles. Because ECTV-PH was over-
expressed using a T7 promoter, it is possible that the pro-
tein was more widely distributed than when it is expressed
Investigation of colocalization of ECTV-PH and cellular tro-pomyosin by immunof uorescenceFigure 11
Investigation of colocalization of ECTV-PH and cellular tro-
pomyosin by immunofluorescence. Myc-tagged ECTV-PH 
was overexpressed in virus-infected BS-C-1 cells using a 
vTF7-3 transient expression system. (A) Mock-infected con-
trol cells stained with anti-tropomyosin antibodies and visual-
ized with FITC (green) show a relatively uniform distribution 
of endogenous tropomyosin throughout the cytoplasm. DAPI 
staining (blue) shows the cellular nuclei. See Figure 9A for 
the corresponding anti-Myc control. (B) DAPI staining shows 
the cellular nucleus and viral DNA (blue). (C) Endogenous 
tropomyosin (green), and (D) ECTV-PH (red) are both dis-
tributed throughout the cytoplasm but colocalize to struc-
tures resembling actin tails (arrows labelled 1) and to 
protrusions from the cell surface (arrows labelled 2). ECTV-
PH also localizes in high concentrations to structures resem-
bling inclusion bodies formed by truncated ATI proteins 
(presumably from the recombinant vaccinia used to infect the 
cells (arrows labelled 3)). (E) Merged view of panels (B-D) 
showing colocalization of tropomyosin and ECTV-PH to 
structures at the cell periphery as described above, indicated 
by arrows 1 and 2. Arrows labelled 3 indicate putative inclu-
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Virology Journal 2007, 4:76 http://www.virologyj.com/content/4/1/76at endogenous levels, in effect weakening the visualiza-
tion of concentrated ECTV-PH and making interpretation
of results more difficult.
In a previous study by Blasco et al., cells infected with a
deletion mutant of VACV-WR lacking the profilin
homolog showed normal plaque formation, infectivity,
and IMV/EEV production, movement, and release [32].
This study also showed by fluorescence microscopy that
viral profilin does not associate with actin filaments
within the infected cell. In agreement with this, we did not
detect an interaction between actin and ECTV-PH. How-
ever, we did observe associations between ECTV-PH, tro-
pomyosin and ATI proteins at cellular protrusions and
putative actin tails. It is possible that VACV profilin used
in the Blasco study has functional differences from ECTV-
PH used in our study. It would be interesting to perform a
similar deletion study with ECTV-PH and visualize viral
particle movement using confocal microscopy or
immuno-electron microscopy. Although the profilin pro-
tein sequences are 90% identical between VACV and
ECTV, many genes in the large poxvirus genome are differ-
ent, including the ATI protein that is full-length in ECTV
and truncated in VACV. Another possibility is that VACV
profilin is more connected to processes involving PIP2
than those involving actin (proposed by Machesky et al.
and Blasco et al. [11,32]). Our structural analysis (dis-
cussed earlier) does not dismiss this possibility, though
most of the PIP2 binding residues in the active site are not
conserved. Since both the Blasco study and our study were
done in cell culture, it is possible that during the natural
infection of the host, the associations we observed
between ECTV-PH, tropomyosin and ATI protein may
become important in actin-associated events. Although
not necessarily required for viral particle production and
movement, profilin may have a role to play when present
in this context.
Taken as a whole, the immunofluorescence results sup-
port the idea that ECTV-PH may have some role in intrac-
ellular transport of viral proteins in the cytoplasm or
intercellular spread of the virus. However, further studies
are needed to demonstrate these functions, as well as con-
firm the colocalization of ECTV and tropomyosin within
the cell. Subsequent immunofluorescence studies exam-
ining the association of ECTV-PH, tropomyosin, and ATI
proteins with viral membrane proteins and actin, and
examining the movement of these proteins in infected
cells would provide valuable insight.
Conclusion
In this study, we characterize a profilin homolog, ECTV-
PH, encoded by ectromelia virus. Poxviruses are known to
utilize the cellular cytoskeleton for the transport of virions
and viral components during viral infection, although the
specific mechanisms are not well understood. The ability
of cellular profilin to bind directly to actin and to modu-
late the activities of other actin-binding proteins makes
the viral homolog a candidate for involvement in these
processes.
Our investigation provides evidence that suggests viral
profilin plays a role in protein or viral particle localiza-
tion. We show that ECTV-PH associates with viral ATI pro-
tein in immunoprecitations of infected cells.
Furthermore, immunofluorescence studies show strong
colocalization of ECTV-PH with full-length and truncated
ATI proteins in inclusion bodies. In the case of truncated
ATI protein, colocalization with ECTV-PH also occurs at
protrusions from the cell surface. The formation or utili-
zation of these structures that are involved in the protec-
tion and spread of the virus may be facilitated by the
action of the profilin homolog.
ECTV-PH also directly associates with cellular tropomy-
osin, an actin-binding protein and regulator of actin fila-
ment function and stability. The extent to which ECTV-PH
and tropomyosin colocalize in immunoflourescence stud-
ies is less clear; however, our results raise the possibility
that ECTV-PH and tropomyosin may associate at protru-
sions from the cell surface and putative actin tails. These
data support a potential role for these proteins in intracel-
lular transport of IMVs or viral proteins, or intercellular
spread of the virus.
Three-dimensional modelling showed that although the
viral profilin homolog shares only 31% and 23% amino
acid identity with mammalian profilin 1 and 3 respec-
tively, the overall structure of the proteins are very similar.
The lack of conservation of residues known in human pro-
filin to be involved in binding of actin, poly(L-proline),
and PIP2 suggests that the function of the poxviral
homolog may be quite different from cellular profilins
and illustrates how genes that are hijacked by viruses may
be rapidly modified and apparently new functions
selected for (e.g. binding of viral ATI protein). It is inter-
esting that although the primary sequences have diverged
considerably, the structures have to a large degree been
maintained. This suggests that there is an inherent value
to a stable protein structure that can support a variety of
functional interaction surfaces. Also, since cellular profi-
lins are known to interact with multiple protein and phos-
phoinositide ligands, it is possible that the poxvirus
profilin homologs have maintained some of these interac-
tions that were not detected in our immunoprecipitation
experiment. Low protein concentration or either weak or
transient interactions could result in such interactions
being undetected. The conservation of profilin-like genes
in current orthopoxviruses (greater than 90% aa identity)
indicates that these proteins perform an important func-
tion during viral infection. Further characterization of the
mechanisms by which poxviruses manipulate the
cytoskeleton will not only result in a deeper understand-
ing of the virus-host relationship, but may also give a freshPage 11 of 15
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ize and control the actin cytoskeleton.
Methods
Sequence Analysis
All poxviral protein sequences were obtained from the
Viral Orthologous Clusters (VOCs) database [6,7]. Other
sequences were retrieved from GenBank: human profilin
1 (NP_005013), profilin 2 isoform a (NP_444252), profi-
lin 2 isoform b (NP_002619), and profilin 3
(NP_001025057); Bos taurus profilin 1 (NP_001015592),
profilin 2 (Q09430), and profilin 3 (NP_001071413);
Mus musculus profilin 1 (NP_035202), profilin 2
(NP_062283), and profilin 3 (NP_083579); Rattus nor-
vegicus profilin 1 (NP_071956), profilin 2 (NP_110500),
and profilin 3 (XP_001065833). Multiple sequence align-
ments and percent identity tables were created with Base-
By-Base [33] using the T-Coffee alignment algorithm [34]
with minor manual adjustments to the profilin alignment
based on structural analysis.
Phylogenetic trees were constructed from 14 aligned pro-
filin amino acid sequences using the PHYLIP package
[35]. The maximum likelihood tree was calculated with
the "proml" program, using the Jones-Taylor-Thornton
model of amino acid substitution [36], with a constant
rate of change across sites, and allowing global rearrange-
ments. The input sequence order was randomized 5 times,
and from the resulting 5 output trees, the highest-scoring
tree was selected. The maximum parsimony tree (data not
shown) was calculated with the "protpars" program, using
ordinary parsimony, with all sites equally weighted. Input
order was again randomized 5 times, and the best tree
chosen from the 5 trials. Bootstrap values were created
using "seqboot" to generate 100 bootstrap samples of the
input sequences. For both maximum parsimony and max-
imum likelihood, trees were computed for all bootstrap
data sets using the same parameters as the original data;
the consensus trees and bootstrap values were calculated
using "consense". Trees were drawn with the "drawtree"
program, and edited with the Xfig Drawing Program for
the X Window System [37].
Homology modelling
The ECTV-PH primary protein sequence (NP_671660.1)
was submitted to the SWISS-MODEL [17] server using the
"First Approach" mode with default settings. The server
identified 4 profilin proteins as having a high degree of
sequence identity with ECTV-PH based on BLASTp results
[38]. These 4 profilins were then used for the ECTV-PH
structural model: human platelet profilin 1 (high salt;
1FIL; [18], human platelet profilin 1 (low salt; 1FIK; [18]),
human profilin NMR structure (1PFL; [39]), and bovine
profilin complexed with beta-actin (1HLU; [40]). The
homology model of ECTV-PH was superimposed and
subsequently compared to the crystal structure of human
profilin 1 (1FIL) using the MatchMaker feature of the Chi-
mera visualization software [41]. The structural model of
ECTV-PH was confirmed by modelling the primary
sequence of ECTV-PH using the Robetta protein structure
prediction server [20-22] using the human platelet profi-
lin crystal structure as a template (1CJF chain A; [42]).
The primary protein sequence of the human profilin 3
protein (NP_001025057.1) was also modelled with
SWISS-MODEL [17] using default settings. The SWISS-
MODEL server modelled the structure of human profilin
3 based on 4 profilin proteins; human platelet profilin 1
(low salt; 1FIK; [18]), human platelet profilin 1 (high salt;
1FIL; [18]), human profilin 1 NMR structure (1PFL; [39]),
and human platelet profilin 1 complexed with a proline-
rich ligand (1CF0; [42]). A structural model for human
profilin 2a (data not shown) was created using SWISS-
MODEL in the same manner as both ECTV-PH, and
human profilin 3, using the following protein crystal
structures as templates: human profilin 2b (1D1J; [19])
and bovine profilin complexed with beta-actin (1HLU;
[40]).
Expression and purification of recombinant proteins
The polymerase chain reaction (PCR) was utilized to
amplify the target genes from ECTV-Moscow DNA and
incorporate a primer sequence encoding a 6-histidine tag
onto the 5' end of each gene. PCR products were cloned
into the pENTR/SD/D-Topo entry vector, and then sub-
cloned into the pDEST14 destination vector to generate
expression clones as per the manufacturer's instructions
(Invitrogen Life Technologies, Carlsbad, CA, USA). A
recombinant VACV strain WR vTF7-3 (ATCC VR-2153;
[43]) expressing a T7 polymerase was used to transiently
overexpress His-tagged ECTV-PH in BS-C-1 cells. Tissue
culture reagents were obtained from Gibco BRL Inc.
(Gaithersburg, MD, USA). The African green monkey kid-
ney cell line BS-C-1 (ATCC CCL 26), was grown in com-
plete Dulbecco's modified Eagle medium supplemented
with 10% newborn bovine serum, 50 U/ml penicillin, 50
μg/ml streptomycin and GlutaMAX-II (Gibco). BS-C-1
cells were lysed using a French Pressure Cell (American
Instrument Company, Silver Spring, Maryland, USA) and
His-tagged ECTV-PH was purified using a Ni-NTA column
(Invitrogen Life Technologies) with a Bio-Rad Biologic
low-pressure chromatography system and a 0–300 mM
imidazole elution gradient (Bio-Rad, Richmond, CA,
USA). EDTA and glycerol were added to the fractions
(final concentrations of 1 mM and 10%, respectively) to
prevent degradation and aggregation of the proteins,
which were then stored at -20°C. Protein concentrations
were determined using Bradford Reagent (Sigma-Aldrich,
Oakville, ON, Canada) following manufacturer's instruc-
tions.
Western blots
Purified protein or cellular lysates were separated by SDS-
PAGE on pre-cast NuPAGE Novex 4 – 12% Bis-Tris 12 wellPage 12 of 15
(page number not for citation purposes)
Virology Journal 2007, 4:76 http://www.virologyj.com/content/4/1/76gels (Cat # NP0322BOX, Invitrogen Life Technologies)
using an Xcell SureLock Mini-cell apparatus as per the
manufacturer's instructions (Invitrogen Life Technolo-
gies). The proteins were transferred to a Trans-Blot nitro-
cellulose membrane (Cat #12011, Bio-Rad) using a Bio-
Rad mini trans-blot cell apparatus as per the manufac-
turer's instructions (Bio-Rad). The blot was detected with
a 1:1500 dilution of primary antibody and a 1:2500 dilu-
tion of secondary antibody as follows. His-tagged proteins
were detected and visualized using mouse IgG1 anti-penta
His primary antibody (Cat # 34660, QIAGEN, Chats-
worth, CA, USA) and rabbit anti-mouse IgG (H&L) IRDye
800 conjugate secondary antibody (Cat # 610432020,
Rockland Immunochemicals Inc., Gilbertsville, PA, USA).
Myc-tagged proteins were detected and visualized using
rabbit polyclonal anti-Myc primary antibody (Cat # 2272,
Cell Signalling Technology, Beverly, MA, USA) and goat
anti-rabbit IgG (H&L) IRDye 800 conjugate secondary
antibody (Cat # 611132122, Rockland Immunochemi-
cals Inc.). HA-tagged proteins were detected and visual-
ized using mouse IgG1 anti-HA Alexa Fluor 488 conjugate
antibody (Cat # A21287, Molecular Probes Inc., Eugene,
OR, USA) and rabbit anti-mouse IgG (H&L) IRDye 800
conjugate secondary antibody (Cat # 610432020, Rock-
land Immunochemicals Inc.). Actin was detected and vis-
ualized using rabbit IgG anti-actin primary antibody (Cat
# A5060, Sigma-Aldrich) and goat anti-rabbit IgG (H&L)
IRDye 800 conjugate secondary antibody (Cat #
611132122, Rockland Immunochemicals Inc.). Blots
were visualized and digitally photographed using the
Odyssey Infrared Imaging System (model 9120, Li-COR
Biosciences, Lincoln, NB, USA).
Immunoprecipitation
BS-C-1 cells were seeded in 9 × 100 mm tissue culture
dishes and grown to 90% confluency (approximately 6.3
× 107 cells/dish). Cells were infected with a recombinant
VACV strain WR vTF7-3 (ATCC VR-2153) expressing a T7
polymerase, at a multiplicity of infection (MOI) of 10,
and then transfected with 25 μg ECTV-Moscow 141 (His-
tagged) pDEST14 Expression Clone plasmid DNA per 100
mm dish. After 16 h incubation, cells were washed with
PBS and lysed with non-denaturing lysis buffer (50 mM
Tris-HCl pH 7.5, 300 mM NaCl, 1% Triton ×-100, 10 mM
imidazole) containing protease inhibitor cocktail (Cat #
1836153, Roche Applied Science, Indianapolis, IN, USA).
After centrifugation at 20,000 ×g for 10 min at 4°C, the
lysate supernatant fluid was added to 15 μl Protein G-Plus
Agarose (Cat # sc2002, Santa Cruz Biotechnology, Santa
Cruz, CA, USA) to pre-clear the extract. Following rotation
of the tube at 4°C for 1 h, the Protein G-Plus Agarose was
pelleted by centrifuging at 1000 × g for 1 min and Penta-
His Antibody (Cat # 34660, mouse Penta-His Antibody
IgG1, QIAGEN) was added to the supernatant fluid to a
final concentration of 5 μg/ml. The tube was rotated for 3
h at 4°C before 60 μl Protein G-Plus Agarose was added
and the incubation continued overnight. After ~ 16 h, the
Protein G-Plus Agarose was pelleted by centrifuging at
1000 × g for 1 min and the supernatant fluid was
removed. The agarose was washed 4 times in 3 ml of wash
buffer (0.1% Triton ×-100, 50 mM Tris-HCl, pH 7.5, 300
mM NaCl) and once with PBS. The pellet was resus-
pended in 80 μl of 1 × NuPAGE LDS sample buffer (Cat #
NP0007, Invitrogen Life Technologies) containing 10 mM
DTT (dithiothreitol), then heated to 70°C for 10 min and
subjected to SDS-PAGE and western blot. The control
used herring sperm DNA instead of pDEST14 expression
clone DNA.
Mass spectrometry
Coomassie blue-stained bands were excised from an SDS-
PAGE gel using a new scalpel for each band and were pre-
pared and analyzed by the Genome BC Proteomics Centre
(Victoria, BC, Canada). The gel slices were subjected to an
automated in-gel trypsin digestion, and the proteins
obtained were analyzed by MALDI-TOF using a Voyager-
DE STR mass spectrometer (Applied Biosystems, Foster
City, CA, USA). The Mascot search engine [44] was used
to identify the primary protein sequences of the samples
from the mass spectrometry data by searching primary
sequence databases.
Far western analysis
2 μg each of porcine muscle tropomyosin (Cat # T2400,
Sigma-Aldrich), ECTV-PH (His-tagged, metal chelation
chromatography purified), rabbit muscle actin (Cat #
A2522, Sigma-Aldrich), RelA (His-tagged bacterial pro-
tein, a gift from Dr. Edward Ishiguro, Dept. Biochemistry
and Microbiology, University of Victoria), and Bovine
Serum Albumin (BSA; Cat # A9647, Sigma-Aldrich) were
separated by SDS-PAGE. After transfer to a nitrocellulose
membrane, proteins were refolded by a denaturation and
renaturation cycle in guanidine hydrochloride as
described by Rea et al. [45]. The membrane was washed
twice in 50 ml of denaturation buffer (6 M guanidine
hydrochloride, 20 mM HEPES pH 7.5, 50 mM KCl, 10
mM MgCl2, 1 mM DTT, 0.1% Nonidet P-40) for 10 min at
4°C with gentle agitation. The denaturation buffer was
diluted 1:1 with basic buffer (20 mM HEPES pH 7.5, 50
mM KCl, 10 mM MgCl2, 1 mM DTT, 0.1% Nonidet P-40)
and the membrane was washed as before. This dilution
and wash cycle was repeated four more times until the
final wash contained 175 mM guanidinium hydrochlo-
ride. Porcine muscle tropomyosin was used as the probe
protein, and was diluted to a final concentration of 20 μg/
ml in interaction buffer (1% nonfat dry milk in basic
buffer, 5% glycerol, 1 mM PMSF) and was incubated with
the membrane for 5 h at 4°C with gentle agitation. The
tropomyosin solution was removed and the membrane
was washed 4 × 10 min in buffer #1 (0.2% Triton ×-100 in
PBS) at 4°C with gentle agitation, followed by 2 × 10 min
in buffer #2 (0.2% Triton ×-100, 100 mM KCl in PBS) atPage 13 of 15
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mouse monoclonal anti-tropomyosin IgG1 primary anti-
body (Cat # T2780, Sigma-Aldrich) diluted 1:1000 in 1:1
Odyssey Blocking Buffer and PBS + 0.2% TWEEN-20,
overnight at 4°C with gentle agitation. The next day the
primary antibody was removed and the membrane was
washed 4 × 5 min with PBS + 0.1% TWEEN-20. The mem-
brane was then exposed to rabbit anti-mouse IgG (H&L)
IRDye 800 conjugate secondary antibody (Cat #
610432020, Rockland Immunochemicals Inc.) at a
1:2500 dilution for 1 h at 4°C with gentle agitation. The
secondary antibody was removed and the membrane was
washed 4 × 5 min with PBS + 0.1% TWEEN-20 and once
with PBS alone. The blot was visualized and digitally pho-
tographed using the Odyssey Infrared Imaging System (Li-
COR Biosciences).
Immunofluorescence
BS-C-1 cells were grown on cover slips to 80% confluency,
infected with recombinant VACV-WR strain vTF7-3
(ATCC VR-2153; MOI = 10), transfected with 200 ng
pDEST14 expression clone plasmid DNA per chamber
and incubated for approximately 16 h. After removing
growth medium, cells were washed once with RT Tris-
buffered saline (TBS; 150 mM Tris-HCl pH 7.4, 150 mM
NaCl), fixed for 10 min in 4% paraformaldehyde (in
PBS), washed 5 min with TBS, permeabilized in 0.2% Tri-
ton ×-100 (in PBS) for 5 min at RT and then washed 3 × 5
min each with TBS. Cells were quenched in fresh 0.1%
sodium borohydride (in PBS) for 5 min, washed 3 × 5 min
with TBS, blocked (in 10% fetal bovine serum, 1% BSA,
0.02% NaN3, in PBS) for 1 h at RT with gentle agitation
and finally washed once for 5 min with TBS.
Cells were incubated in primary antibody diluted in 1%
BSA (in TBS) overnight at 4°C with gentle agitation,
washed 3 × 5 min with TBS and then incubated with sec-
ondary antibody diluted in 1% BSA (in TBS) at RT in the
dark for 45 min. Proteins containing a Myc tag were visu-
alized using rabbit polyclonal anti-Myc primary antibody
(Cat # 2272, Cell Signalling Technology) 1:100 dilution,
and Alexa Fluor 568 conjugate goat anti-rabbit IgG (H+L)
secondary antibody (Cat # A11011, Molecular Probes)
1:200 dilution. Proteins containing a HA tag were visual-
ized using Alexa Fluor 488 conjugate mouse monoclonal
IgG1 anti-HA antibody (Cat # A21287, Molecular Probes)
1:200 dilution. Endogenous cellular tropomyosin was vis-
ualized using mouse monoclonal anti-tropomyosin IgG1
primary antibody (Cat # T2780, Sigma-Aldrich) 1:200
dilution, and goat anti-mouse IgG (whole molecule) FITC
conjugate secondary antibody (Cat # F2012, Sigma-
Aldrich) 1:40 dilution. After incubation with secondary
antibody, cells were washed 3 × 5 min each with TBS in
low lighting, and DNA was visualized by incubation of
cells with DAPI (Cat # D5964, Sigma-Aldrich) at 1 ng/ml
in TBS for 5 min in the dark. Controls used herring sperm
DNA in place of the expression plasmids. After staining
with DAPI, cells were washed 3 × 5 min each with TBS in
low lighting and coverslips were mounted on slides using
the Prolong Antifade Kit (Cat # P7481, Molecular Probes).
Pictures of cells were taken at 1000× magnification using
the Leica DM6000 B microscope (Leica Microsystems,
Richmond Hill, ON, Canada) using the autoexposure
option.
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